• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  04/22/2011
Trade Name:  Menactra
Generic or Proper Name (*):  Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugate Vaccine)*
Indications Studied:  Active immunization of individuals 9 months through 55 years of age for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135
Therapeutic Category:  Preventive Vaccine
Ages Studied:  9 - <13 months
Study #:  1
Study Type:  Safety/Immunogenicity
Study Design:  Randomized/Open label, Controlled
No Patients:  1257
No Centers:  71
No Countries:  1